Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Gasoline Fund Lp
UGA
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
No Data
Iovance's Terminated TIL Study Reshapes Expectations for Solid-Tumor Growth
Barclays Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $11
Iovance Biotherapeutics Signals Strong Momentum in Call
A Quick Look at Today's Ratings for Iovance Biotherapeutics(IOVA.US), With a Forecast Between $5 to $14
Barclays Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)
Chardan Capital Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $14